Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection
Authors:
Open Access
- 23 July 2004
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 76 (4) , 368-372
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Autologous Epstein-Barr virus (EBV)–specific cytotoxic T cells for the treatment of persistent active EBV infectionBlood, 2002
- Chronic active Epstein–Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 2002
- Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein–Barr virus infectionBone Marrow Transplantation, 2000
- Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.The Lancet, 2000
- Interferon-α Therapy for Chronic Active Epstein-Barr Virus InfectionJournal of Pediatric Hematology/Oncology, 1998
- Bone marrow transplatation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosisBone Marrow Transplantation, 1997
- Chronic active Epstein‐Barr virus infection in children in JapanActa Paediatrica, 1995
- Production of Genetically Modified Epstein-Barr Virus-Specific Cytotoxic T Cells for Adoptive Transfer to Patients at High Risk of EBV-Associated Lymphoproliferative DiseaseJournal of Hematotherapy, 1995
- Ganciclovir for chronic active Epstein-Barr virus infectionThe Lancet, 1993
- SUCCESSFUL TREATMENT OF CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION WITH RECOMBINANT INTERLEUKIN-2The Lancet, 1987